Dr. Ron Farkas

Sarepta Therapeutics Inc (NASDAQ: SRPT) shares are up more than 20 percent today. So what exactly is boosting the stock to levels it hasn't seen since January? On Tuesday night, Jenn McNary, a mother of two children suffering from Duchenne muscular dystrophy, Tweeted that Dr. Ron Farkas, a...

The "miracle drug" that could save the lives and well-being for hundreds of people may have just received some great news. Dr. Ron Farkas has left the U.S. Food & Drug Administration, people familiar with the matter told Benzinga. Why would his departure raise hope for the "...